PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosis

Annals of Pediatric Cardiology

Volumn 8, Issue 2, 2015, Pages 153-156

  Aggarwal, Varun ^a   Dobrolet, Nancy ^a   Fishberger, Steven ^a   Zablah, Jenny ^a   Jayakar, Parul ^a   Ammous, Zineb ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Arrhythmia; hypertrophic cardiomyopathy; PRKAG 2 mutation; WPW syndrome

Indexed keywords

ATENOLOL; PROCAINAMIDE; PROTEIN; PROTEIN PRKAG2; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR CONDUCTION; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CASE REPORT; DIAGNOSTIC ERROR; ELECTROCARDIOGRAPHY; FAINTNESS; FAMILY HISTORY; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GLYCOGEN STORAGE DISEASE; HEART ATRIOVENTRICULAR NODE; HEART LEFT VENTRICLE HYPERTROPHY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MISSENSE MUTATION; PREVALENCE; SARCOMERE; SINUS RHYTHM; TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

EID: 84930342791     PISSN: 09742069     EISSN: 09745149     Source Type: Journal    
DOI: 10.4103/0974-2069.154149     Document Type: Article

References (13)

1. Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: Management and follow-up. J Am Coll Cardiol 1985; 5: 130-5
2. Doevendans PA, Wellens HJ. Wolff-Parkinson-white syndrome: A genetic disease? Circulation 2001; 104: 3014-6
3. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, et al. Identi?cation of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344: 1823-31
4. Ehtisham J, Watkins H. Is Wolff-Parkinson-White syndrome a genetic disease? J Cardiovasc Electrophysiol 2005; 16: 1258-62
5. Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001; 104: 3030-3
6. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: From mutation identi?cation to mechanistic paradigms. Cell 2001; 104: 557-67
7. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, et al. EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-32
8. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995; 96: 1216-20
9. Sidhu J, Roberts R. Genetic basis and pathogenesis of familial WPW syndrome. Indian Pacing Electrophysiol J 2003; 3: 197-201
10. Gollob MH, Green MS, Tang AS, Roberts R. PRKAG2 cardiac syndrome: Familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr Opin Cardiol 2002; 17: 229-34
11. Kemp BE, Mitchell KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: The AMPactivated protein kinase. Trends Biochem Sci 1999; 24: 22-5
12. Wolf CM, Arad M, Ahmad F, Sanbe A, Bernstein SA, Toka O, et al. Reversibility of PRKAG2 glycogenstorage cardiomyopathy and electrophysiological manifestations. Circulation 2008; 117: 144-54
13. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, et al. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 2008; 358: 1899-908